Table 1.
Activation curve* | Availability curve** | |||
---|---|---|---|---|
E0.5(mV) | ka (mV) | h0.5(mV) | kh (mV) | |
TTX-R | ||||
Control cells (n = 6) | ||||
Baseline | −14.49 ± 1.29 | 5.59 ± 0.72 | −24.75 ± 0.44a | 4.76 ± 0.02 |
10 min | −16.67 ± 1.35 | 6.13 ± 0.70 | −25.67 ± 0.53 | 5.29 ± 0.00 |
20 min | −14.11 ± 0.87 | 5.95 ± 0.67 | ||
Δ[10 min − baseline] | −2.17 ± 0.42 | 1.03 ± 0.54 | −0.92 ± 0.09 | 0.53 ± 0.02 |
ET-1 responsive cells (n = 10) | ||||
Baseline | −18.94 ± 1.42 | 5.39 ± 0.25 | −27.26 ± 1.48 | 5.33 ± 0.10 |
ET-1 | −26.98 ± 1.34 | 4.64 ± 0.27 | −32.44 ± 1.50 | 6.02 ± 0.29 |
Δ[ET-1 − baseline] | −8.04 ± 0.54 | 0.75 ± 0.27 | −5.18 ± 0.37 | 0.69 ± 0.26 |
ET-1 non-responsive cells (n = 7) | ||||
Baseline | −13.33 ± 2.20 | 5.93 ± 0.45 | −20.57 ± 0.35b | 5.33 ± 0.03 |
ET-1 | −15.58 ± 2.34 | 4.64 ± 0.27 | −22.81 ± 0.38 | 5.93 ± 0.04 |
Δ[ET-1 − baseline] | −3.25 ± 0.18 | 0.07 ± 0.17 | −2.24 ± −0.03 | 0.60 ± 0.03 |
BQ-123 plus ET-1-treated cells (n = 10) | ||||
Baseline | −10.27 ± 1.85 | 6.67 ± 0.36 | −23.55 ± 1.85 | 6.41 ± 0.34 |
BQ-123 | −12.34 ± 1.84 | 5.94 ± 0.37 | −25.12 ± 2.02 | 6.51 ± 0.56 |
BQ-123 plus ET-1 | −13.93 ± 1.90 | 6.13 ± 0.24 | −29.05 ± 2.11 | 6.63 ± 0.38 |
Δ[BQ-123 − baseline] | −2.07 ± 0.61 | 1.54 ± 0.45 | −1.85 ± 0.50 | 0.13 ± 0.30 |
Δ[(BQ-123 + ET-1) − BQ-123] | −1.54 ± 0.45 | 0.19 ± 0.17 | −2.90 ± 0.35 | 0.07 ± 0.26 |
TTX-S (n = 7) | ||||
Baseline | −14.49 ± 1.29 | 5.59 ± 0.72 | −24.75 ± 0.44 | 4.76 ± 0.02 |
ET-1 | −16.67 ± 1.35 | 5.95 ± 0.67 | −25.67 ± 0.53 | 5.29 ± 0.01 |
Δ[ET-1 − baseline] | −2.17 ± 0.42 | 1.03 ± 0.54 | −0.92 ± 0.09 | 0.53 ± 0.02 |
All values listed are means ± SEM. *Boltzmann equation for fitting the activation curve is as follows:G/Gmax = {1 + exp[−(E −E0.5)/ka]}−1. **Boltzmann equation for fitting the availability curve is as follows:I/Imax = (Amax− A0)/{1 + exp[(h0.5 −E)/kh]} +A0.
n = 4.
n = 4.